Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
21.14
-0.51 (-2.36%)
Feb 5, 2026, 3:44 PM EST - Market open
Roivant Sciences Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 1,237 | 2,715 | 6,495 | 1,677 | 2,060 | 2,055 |
Short-Term Investments | 3,149 | 2,171 | - | - | - | - |
Cash & Short-Term Investments | 4,386 | 4,887 | 6,495 | 1,677 | 2,060 | 2,055 |
Cash Growth | -18.58% | -24.76% | 287.34% | -18.62% | 0.26% | -5.87% |
Accounts Receivable | - | - | - | 30.38 | 3.88 | - |
Other Receivables | - | - | - | 7.27 | 2.85 | - |
Receivables | - | - | - | 37.64 | 6.73 | - |
Inventory | - | - | - | 2.76 | - | - |
Prepaid Expenses | - | - | - | 60.83 | 53.37 | - |
Restricted Cash | 2.26 | 2.36 | 3.07 | 5.01 | 3.9 | 77.7 |
Other Current Assets | 123.55 | 110.82 | 233.81 | 15.53 | 22.12 | 54.25 |
Total Current Assets | 4,512 | 5,000 | 6,732 | 1,799 | 2,147 | 2,187 |
Property, Plant & Equipment | 110.8 | 101.08 | 59.32 | 92.34 | 86.95 | 77.03 |
Long-Term Investments | 412.32 | 302.94 | 247.75 | 304.32 | 325.83 | 289.54 |
Other Intangible Assets | - | - | - | 144.88 | - | - |
Other Long-Term Assets | 27.83 | 32.86 | 183.58 | 49.48 | 25.82 | 36.13 |
Total Assets | 5,063 | 5,437 | 7,222 | 2,390 | 2,585 | 2,590 |
Accounts Payable | 15.06 | 23.69 | 14.03 | 37.83 | 34.58 | 20.55 |
Accrued Expenses | 108.32 | 114.29 | 119.42 | 167.13 | 127.53 | 76.94 |
Current Portion of Long-Term Debt | - | - | - | 40.72 | - | - |
Current Portion of Leases | 9 | 9.84 | 8.97 | 11.69 | 11.4 | 12.31 |
Current Income Taxes Payable | - | 0.42 | 9.77 | 0.54 | 0.71 | - |
Current Unearned Revenue | - | 1.17 | 4.17 | 12.44 | 10.15 | 5.92 |
Other Current Liabilities | 1.48 | - | 110.41 | 2.09 | - | 103.24 |
Total Current Liabilities | 133.86 | 149.41 | 266.76 | 272.45 | 184.37 | 218.96 |
Long-Term Debt | - | - | - | 375.52 | 210.03 | 170.28 |
Long-Term Leases | 89.84 | 90.33 | 45.02 | 53.48 | 62.47 | 62.38 |
Other Long-Term Liabilities | 33.44 | 10 | 462.18 | 80.58 | 66.84 | 76.06 |
Total Liabilities | 257.14 | 249.74 | 773.95 | 782.02 | 523.7 | 527.69 |
Additional Paid-In Capital | 4,772 | 4,562 | 5,396 | 4,933 | 4,422 | 3,815 |
Retained Earnings | -429.11 | 116.06 | 576.17 | -3,773 | -2,764 | -1,918 |
Comprehensive Income & Other | 19.56 | 9.44 | -4.08 | -2.62 | -0.95 | -98.56 |
Total Common Equity | 4,362 | 4,688 | 5,969 | 1,158 | 1,657 | 1,798 |
Minority Interest | 443.13 | 499.59 | 479.95 | 449.82 | 404.49 | 264.22 |
Shareholders' Equity | 4,805 | 5,187 | 6,449 | 1,608 | 2,061 | 2,062 |
Total Liabilities & Equity | 5,063 | 5,437 | 7,222 | 2,390 | 2,585 | 2,590 |
Total Debt | 98.85 | 100.17 | 53.99 | 481.4 | 283.89 | 244.98 |
Net Cash (Debt) | 4,287 | 4,787 | 6,441 | 1,195 | 1,777 | 1,810 |
Net Cash Growth | -19.63% | -25.68% | 438.81% | -32.71% | -1.85% | -9.60% |
Net Cash Per Share | 6.14 | 6.60 | 7.75 | 1.68 | 2.65 | 2.87 |
Filing Date Shares Outstanding | 695.49 | 679.81 | 738.72 | 766.81 | 700.77 | 222.67 |
Total Common Shares Outstanding | 689.7 | 695.94 | 806.68 | 760.14 | 694.98 | 222.67 |
Working Capital | 4,378 | 4,851 | 6,465 | 1,526 | 1,962 | 1,968 |
Book Value Per Share | 6.32 | 6.74 | 7.40 | 1.52 | 2.38 | 8.07 |
Tangible Book Value | 4,362 | 4,688 | 5,969 | 1,013 | 1,657 | 1,798 |
Tangible Book Value Per Share | 6.32 | 6.74 | 7.40 | 1.33 | 2.38 | 8.07 |
Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.